KATHRYN FRANCESCON: Open Payments
NPI 1457501751 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,738 in 131 payments from 36 companies in 2025. Trend: 2023 $1,730 · 2024 $2,125 · 2025 $2,738
Food & beverage: $2,623Education: $116
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $295 |
| Novartis Pharmaceuticals Corporation | 15 | $259 |
| AstraZeneca Pharmaceuticals LP | 7 | $210 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $184 |
| ABBVIE INC. | 10 | $178 |
| Janssen Biotech, Inc. | 9 | $165 |
| Daiichi Sankyo Inc. | 7 | $144 |
| Merck Sharp & Dohme LLC | 6 | $107 |
| Aveo Pharmaceuticals, Inc. | 5 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
Products named: PADCEV, KEYTRUDA, FRUZAQLA, KISQALI, Enhertu, RYBREVANT, VENCLEXTA, FOTIVDA.
Industry payments across KY — which companies pay providers there.
